THE SHARE: Change: 0.00 SEK (-3.86%) / Price: 0.11 SEK / Apr 15, 2026, 6:00 pm (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

  • 12 Oct, 2021
    Spago Nanomedicals CDO är på plats – BioStock
  • 21 Jun, 2021
    Spago Nanomedical’s CEO about the plans for the coming twelve months – BioStock
  • 21 Jun, 2021
    Spago Nanomedicals vd om planerna för de kommande tolv månaderna – BioStock
  • 21 May, 2021
    Spago Nanomedical will present at Erik Penser Imaging event on May 25
  • 26 Mar, 2021
    Spago Nanomedical enters Nasdaq First North Growth Market – BioStock
  • 1
  • 2
  • 3
  • 4
  • Previous
Back

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2026 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications